Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP251148.RAkXEq7Xezj-ahH2KO2_GRDZ0QeHUnJMkDuNaP4-DQtdc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP251148.RAkXEq7Xezj-ahH2KO2_GRDZ0QeHUnJMkDuNaP4-DQtdc130_assertion type Assertion NP251148.RAkXEq7Xezj-ahH2KO2_GRDZ0QeHUnJMkDuNaP4-DQtdc130_head.
- NP251148.RAkXEq7Xezj-ahH2KO2_GRDZ0QeHUnJMkDuNaP4-DQtdc130_assertion description "[In addition to increased B-cell lymphoma 2 (Bcl-2) phosphorylation through JNK signaling in response to docetaxel, si-Vav3 enhanced docetaxel-induced apoptosis, as characterized by the accumulation of sub-G1 phase cells and DNA fragmentation, through Bcl-xL/Bcl-2-associated death promoter (Bad) dephosphorylation, resulting in increased caspase-9, caspase-3, and cleaved poly(ADP-ribose) polymerase activation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP251148.RAkXEq7Xezj-ahH2KO2_GRDZ0QeHUnJMkDuNaP4-DQtdc130_provenance.
- NP251148.RAkXEq7Xezj-ahH2KO2_GRDZ0QeHUnJMkDuNaP4-DQtdc130_assertion evidence source_evidence_literature NP251148.RAkXEq7Xezj-ahH2KO2_GRDZ0QeHUnJMkDuNaP4-DQtdc130_provenance.
- NP251148.RAkXEq7Xezj-ahH2KO2_GRDZ0QeHUnJMkDuNaP4-DQtdc130_assertion SIO_000772 23566222 NP251148.RAkXEq7Xezj-ahH2KO2_GRDZ0QeHUnJMkDuNaP4-DQtdc130_provenance.
- NP251148.RAkXEq7Xezj-ahH2KO2_GRDZ0QeHUnJMkDuNaP4-DQtdc130_assertion wasDerivedFrom befree-20140225 NP251148.RAkXEq7Xezj-ahH2KO2_GRDZ0QeHUnJMkDuNaP4-DQtdc130_provenance.
- NP251148.RAkXEq7Xezj-ahH2KO2_GRDZ0QeHUnJMkDuNaP4-DQtdc130_assertion wasGeneratedBy ECO_0000203 NP251148.RAkXEq7Xezj-ahH2KO2_GRDZ0QeHUnJMkDuNaP4-DQtdc130_provenance.